| Year |
Citation |
Score |
| 2023 |
Benabdallah N, Lu P, Abou DS, Zhang H, Ulmert D, Hobbs RF, Gay HA, Simons BW, Saeed MA, Rogers BE, Jha AK, Tai YC, Malone CD, Ippolito JE, Michalski J, et al. Beyond Average: α-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 38124163 DOI: 10.2967/jnumed.123.266571 |
0.53 |
|
| 2023 |
Seitzman BA, Reynoso FJ, Mitchell TJ, Bice AR, Jarang A, Wang X, Mpoy C, Strong L, Rogers BE, Yuede CM, Rubin JB, Perkins SM, Bauer AQ. Functional network disorganization and cognitive decline following fractionated whole-brain radiation in mice. Geroscience. PMID 37749370 DOI: 10.1007/s11357-023-00944-w |
0.516 |
|
| 2023 |
Sreekumar S, Zhou D, Mpoy C, Schenk E, Scott J, Arbeit JM, Xu J, Rogers BE. Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer. International Journal of Molecular Sciences. 24. PMID 36834491 DOI: 10.3390/ijms24043083 |
0.564 |
|
| 2022 |
Terpstra K, Wang Y, Huynh TT, Bandara N, Cho HJ, Rogers BE, Mirica LM. Divalent 2-(4-Hydroxyphenyl)benzothiazole Bifunctional Chelators for Cu Positron Emission Tomography Imaging in Alzheimer's Disease. Inorganic Chemistry. PMID 36463521 DOI: 10.1021/acs.inorgchem.2c02740 |
0.61 |
|
| 2022 |
Kang CS, Zhang S, Wang H, Liu Y, Ren S, Chen Y, Li J, Bandara N, Rogachev AY, Rogers BE, Chong HS. Novel Chelating Agents for Zirconium-89-Positron Emission Tomography (PET) Imaging: Synthesis, DFT Calculation, Radiolabeling, and and Complex Stability. Acs Omega. 7: 37229-37236. PMID 36312419 DOI: 10.1021/acsomega.2c03478 |
0.578 |
|
| 2022 |
Xu J, Chen H, Rogers BE, Katzenellenbogen JA, Zhou D. Solid phase radiosynthesis of an olaparib derivative using 4-[F] fluorobenzoic acid and in vivo evaluation in breast and prostate cancer xenograft models for PARP-1 expression. Nuclear Medicine and Biology. 65-70. PMID 36193598 DOI: 10.1016/j.nucmedbio.2022.09.002 |
0.528 |
|
| 2022 |
Lander VE, Belle JI, Kingston NL, Herndon JM, Hogg GD, Liu X, Kang LI, Knolhoff BL, Bogner SJ, Baer JM, Zuo C, Borcherding NC, Lander DP, Mpoy C, Scott J, ... Rogers BE, et al. Stromal reprogramming by FAK inhibition overcomes radiation resistance to allow for immune priming and response to checkpoint blockade. Cancer Discovery. PMID 36165893 DOI: 10.1158/2159-8290.CD-22-0192 |
0.561 |
|
| 2022 |
Laforest R, Ghai A, Fraum TJ, Oyama R, Frye J, Kaemmerer H, Gaehle G, Voller T, Mpoy C, Rogers BE, Fiala M, Shoghi KI, Achilefu S, Rettig M, Vij R, et al. First-in-Human Evaluation of Safety and Dosimetry of Cu-LLP2A for PET Imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 36008121 DOI: 10.2967/jnumed.122.264349 |
0.629 |
|
| 2022 |
Zhang H, Abou D, Lu P, Hasson AM, Villmer A, Benabdallah N, Jiang W, Ulmert D, Carlin S, Rogers BE, Turtle NF, McDevitt MR, Baumann B, Simons BW, Dehdashti F, et al. [F]-Labeled PARP-1 PET imaging of PSMA targeted alpha particle radiotherapy response. Scientific Reports. 12: 13034. PMID 35906379 DOI: 10.1038/s41598-022-17460-0 |
0.576 |
|
| 2022 |
Huynh TT, van Dam EM, Sreekumar S, Mpoy C, Blyth BJ, Muntz F, Harris MJ, Rogers BE. Copper-67-Labeled Bombesin Peptide for Targeted Radionuclide Therapy of Prostate Cancer. Pharmaceuticals (Basel, Switzerland). 15. PMID 35745647 DOI: 10.3390/ph15060728 |
0.665 |
|
| 2022 |
Huynh TT, Wang Y, Terpstra K, Cho HJ, Mirica LM, Rogers BE. Ga-Labeled Benzothiazole Derivatives for Imaging Aβ Plaques in Cerebral Amyloid Angiopathy. Acs Omega. 7: 20339-20346. PMID 35721913 DOI: 10.1021/acsomega.2c02369 |
0.555 |
|
| 2022 |
Dehdashti F, Reimers MA, Shoghi KI, Chen DL, Luo J, Rogers B, Pachynski RK, Sreekumar S, Weimholt C, Zhou D. Pilot Study: PARP1 Imaging in Advanced Prostate Cancer. Molecular Imaging and Biology. PMID 35701722 DOI: 10.1007/s11307-022-01746-w |
0.554 |
|
| 2022 |
Huang Y, Huynh TT, Sun L, Hu CH, Wang YC, Rogers BE, Mirica LM. Neutral Ligands as Potential Cu Chelators for Positron Emission Tomography Imaging Applications in Alzheimer's Disease. Inorganic Chemistry. PMID 35245023 DOI: 10.1021/acs.inorgchem.2c00621 |
0.631 |
|
| 2022 |
Huynh TT, Sreekumar S, Mpoy C, Rogers BE. Therapeutic Efficacy of Lu-Labeled A20FMDV2 Peptides Targeting αβ. Pharmaceuticals (Basel, Switzerland). 15. PMID 35215341 DOI: 10.3390/ph15020229 |
0.628 |
|
| 2022 |
Huynh TT, Sreekumar S, Mpoy C, Rogers BE. A comparison of Cu-labeled bi-terminally PEGylated A20FMDV2 peptides targeting integrin αβ. Oncotarget. 13: 360-372. PMID 35186193 DOI: 10.18632/oncotarget.28197 |
0.659 |
|
| 2021 |
Wang Y, Huynh TT, Bandara N, Cho HJ, Rogers BE, Mirica LM. 2-(4-Hydroxyphenyl)benzothiazole dicarboxylate ester TACN chelators for Cu PET imaging in Alzheimer's disease. Dalton Transactions (Cambridge, England : 2003). PMID 34951428 DOI: 10.1039/d1dt02767k |
0.615 |
|
| 2021 |
Benabdallah N, Scheve W, Dunn N, Silvestros D, Schelker P, Abou D, Jammalamadaka U, Laforest R, Li Z, Liu J, Ballard DH, Maughan NM, Gay H, Baumann BC, Hobbs RF, ... Rogers B, et al. Practical considerations for quantitative clinical SPECT/CT imaging of alpha particle emitting radioisotopes. Theranostics. 11: 9721-9737. PMID 34815780 DOI: 10.7150/thno.63860 |
0.554 |
|
| 2021 |
Zhang DM, Navara R, Yin T, Szymanski J, Goldsztejn U, Kenkel C, Lang A, Mpoy C, Lipovsky CE, Qiao Y, Hicks S, Li G, Moore KMS, Bergom C, Rogers BE, et al. Cardiac radiotherapy induces electrical conduction reprogramming in the absence of transmural fibrosis. Nature Communications. 12: 5558. PMID 34561429 DOI: 10.1038/s41467-021-25730-0 |
0.5 |
|
| 2021 |
Wang Y, Huynh TT, Cho HJ, Wang YC, Rogers BE, Mirica LM. Amyloid β-Binding Bifunctional Chelators with Favorable Lipophilicity for Cu Positron Emission Tomography Imaging in Alzheimer's Disease. Inorganic Chemistry. PMID 34351146 DOI: 10.1021/acs.inorgchem.1c02079 |
0.629 |
|
| 2021 |
Sun L, Cho HJ, Sen S, Arango AS, Huynh TT, Huang Y, Bandara N, Rogers BE, Tajkhorshid E, Mirica LM. Amphiphilic Distyrylbenzene Derivatives as Potential Therapeutic and Imaging Agents for Soluble and Insoluble Amyloid β Aggregates in Alzheimer's Disease. Journal of the American Chemical Society. PMID 34213901 DOI: 10.1021/jacs.1c05470 |
0.584 |
|
| 2021 |
Lussier DM, Alspach E, Ward JP, Miceli AP, Runci D, White JM, Mpoy C, Arthur CD, Kohlmiller HN, Jacks T, Artyomov MN, Rogers BE, Schreiber RD. Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loads. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34099555 DOI: 10.1073/pnas.2102611118 |
0.567 |
|
| 2021 |
Zhou D, Chen H, Mpoy C, Afrin S, Rogers BE, Garbow JR, Katzenellenbogen JA, Xu J. Radiosynthesis and Evaluation of Talazoparib and Its Derivatives as PARP-1-Targeting Agents. Biomedicines. 9. PMID 34069967 DOI: 10.3390/biomedicines9050565 |
0.564 |
|
| 2020 |
Huang Y, Cho HJ, Bandara N, Sun L, Tran D, Rogers BE, Mirica LM. Metal-chelating benzothiazole multifunctional compounds for the modulation and Cu PET imaging of Aβ aggregation. Chemical Science. 11: 7789-7799. PMID 34094152 DOI: 10.1039/d0sc02641g |
0.621 |
|
| 2020 |
Chen H, Afrin S, Guo Y, Chu W, Benzinger TLS, Rogers BE, Garbow JR, Perlmutter JS, Zhou D, Xu J. Radiolabeled 6-(2, 3-Dichlorophenyl)-N4-methylpyrimidine-2, 4-diamine (TH287): A Potential Radiotracer for Measuring and Imaging MTH1. International Journal of Molecular Sciences. 21. PMID 33238630 DOI: 10.3390/ijms21228860 |
0.566 |
|
| 2020 |
Cho HJ, Huynh TT, Rogers BE, Mirica LM. Design of a multivalent bifunctional chelator for diagnostic Cu PET imaging in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. PMID 33234563 DOI: 10.1073/pnas.2014058117 |
0.624 |
|
| 2020 |
Rashmi R, Jayachandran K, Zhang J, Menon V, Muhammad N, Zahner M, Ruiz F, Zhang S, Cho K, Wang Y, Huang X, Huang Y, McCormick ML, Rogers BE, Spitz DR, et al. Glutaminase inhibitors induce thiol-mediated oxidative stress and radio-sensitization in treatment resistant cervical cancers. Molecular Cancer Therapeutics. PMID 33087507 DOI: 10.1158/1535-7163.MCT-20-0271 |
0.556 |
|
| 2020 |
Tangadanchu VKR, Jiang H, Yu Y, Graham TJA, Liu H, Rogers BE, Gropler R, Perlmutter J, Tu Z. Structure-activity relationship studies and bioactivity evaluation of 1,2,3-triazole containing analogues as a selective sphingosine kinase-2 inhibitors. European Journal of Medicinal Chemistry. 206: 112713. PMID 32919113 DOI: 10.1016/J.Ejmech.2020.112713 |
0.544 |
|
| 2020 |
Brody SL, Gunsten SP, Luehmann HP, Sultan DH, Hoelscher M, Heo GS, Pan J, Koenitzer JR, Lee EC, Huang T, Mpoy C, Guo S, Laforest R, Salter A, Russell TD, ... ... Rogers BE, et al. Chemokine Receptor 2-targeted Molecular Imaging in Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. PMID 32673071 DOI: 10.1164/Rccm.202004-1132Oc |
0.525 |
|
| 2020 |
Cullinane C, Waldeck K, Kirby L, Rogers BE, Eu P, Tothill RW, Hicks RJ. Enhancing the anti-tumour activity of Lu-DOTA-octreotate radionuclide therapy in somatostatin receptor-2 expressing tumour models by targeting PARP. Scientific Reports. 10: 10196. PMID 32576907 DOI: 10.1038/s41598-020-67199-9 |
0.577 |
|
| 2020 |
Diebolder P, Mpoy C, Scott J, Huynh TT, Fields R, Spitzer D, Bandara N, Rogers BE. Preclinical Evaluation of an Engineered scFv-Fc Targeting Human CD44. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32513906 DOI: 10.2967/Jnumed.120.249557 |
0.783 |
|
| 2020 |
Hegde S, Krisnawan VE, Herzog BH, Zuo C, Breden MA, Knolhoff BL, Hogg GD, Tang JP, Baer JM, Mpoy C, Lee KB, Alexander KA, Rogers BE, Murphy KM, Hawkins WG, et al. Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer. Cancer Cell. 37: 289-307.e9. PMID 32183949 DOI: 10.1016/J.Ccell.2020.02.008 |
0.555 |
|
| 2020 |
Adamo L, Rocha-Resende C, Lin CY, Evans S, Williams JW, Dun H, Li W, Mpoy C, Andhey P, Rogers BE, Lavine K, Kreisel D, Artyomov MN, Randolph GJ, Mann D. Myocardial B cells are a subset of circulating lymphocytes with delayed transit through the heart. Jci Insight. PMID 31945014 DOI: 10.1172/Jci.Insight.134700 |
0.507 |
|
| 2020 |
Huang Y, Cho HJ, Bandara N, Sun L, Tran D, Rogers BE, Mirica LM. Metal-chelating benzothiazole multifunctional compounds for the modulation and 64Cu PET imaging of Aβ aggregation Chemical Science. 11: 7789-7799. DOI: 10.1039/D0Sc02641G |
0.803 |
|
| 2019 |
Bandara N, Li Y, Diebolder P, Mpoy C, Gu X, Khanal P, Deng S, Rogers BE, Savage PB. Translation of ceragenin affinity for bacteria to an imaging reagent for infection. Rsc Advances. 9: 14472-14476. PMID 32864109 DOI: 10.1039/C9Ra02226K |
0.779 |
|
| 2019 |
Floberg JM, Wang L, Bandara N, Rashmi R, Mpoy C, Garbow JR, Rogers BE, Patti GJ, Schwarz JK. Altering cellular reducing potential changes Cu-ATSM signal with or without hypoxia. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31586008 DOI: 10.2967/Jnumed.119.230805 |
0.802 |
|
| 2019 |
Muz B, Bandara N, Mpoy C, Sun J, Alhallak K, Azab F, Rogers BE, Azab AK. CXCR4-targeted PET imaging using Cu-AMD3100 for detection of Waldenström Macroglobulinemia. Cancer Biology & Therapy. 1-9. PMID 31571524 DOI: 10.1080/15384047.2019.1665405 |
0.802 |
|
| 2019 |
Panni RZ, Herndon JM, Zuo C, Hegde S, Hogg GD, Knolhoff BL, Breden MA, Li X, Krisnawan VE, Khan SQ, Schwarz JK, Rogers BE, Fields RC, Hawkins WG, Gupta V, et al. Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies. Science Translational Medicine. 11. PMID 31270275 DOI: 10.1126/Scitranslmed.Aau9240 |
0.574 |
|
| 2019 |
Kapoor V, Singh AK, Rogers BE, Thotala D, Hallahan DE. PEGylated peptide to TIP1 is a novel targeting agent that binds specifically to various cancers in vivo. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30763622 DOI: 10.1016/j.jconrel.2019.02.008 |
0.631 |
|
| 2019 |
Adamo L, Rocha-Resende C, Evans S, Williams J, Dun H, Li W, Mpoy C, Rogers B, Kreisel D, Lavine K, Randolph G, Mann DL. Abstract 114: Myocardial B Cells Regulate the Composition of Leukocytes in the Heart as Well as Myocardial Growth Circulation Research. 125. DOI: 10.1161/Res.125.Suppl_1.114 |
0.506 |
|
| 2019 |
Singh A, Kapoor V, Diebolder P, Rhee A, Rogers B, Thotala D, Hallahan D. Abstract 2377: Development and characterization of scFvs against TIP1/PDZ protein for cancer targeting Cancer Research. 79: 2377-2377. DOI: 10.1158/1538-7445.Am2019-2377 |
0.598 |
|
| 2019 |
Bandara N, Li Y, Diebolder P, Mpoy C, Gu X, Khanal P, Deng S, Rogers BE, Savage PB. Translation of ceragenin affinity for bacteria to an imaging reagent for infection Rsc Advances. 9: 14472-14476. DOI: 10.1039/C9RA02226K |
0.776 |
|
| 2019 |
Bandara N, Jacobson O, Mpoy C, Chen X, Rogers B. Evaluation of a somastostatin receptor based theranostic agent with an albumin binding via structural modifications using a truncated Evans Blue molecule Nuclear Medicine and Biology. DOI: 10.1016/S0969-8051(19)30246-X |
0.77 |
|
| 2018 |
Diebolder P, Vazquez-Pufleau M, Bandara N, Mpoy C, Raliya R, Thimsen E, Biswas P, Rogers BE. Aerosol-synthesized siliceous nanoparticles: impact of morphology and functionalization on biodistribution. International Journal of Nanomedicine. 13: 7375-7393. PMID 30519021 DOI: 10.2147/Ijn.S177350 |
0.741 |
|
| 2018 |
Zhou D, Xu J, Mpoy C, Chu W, Kim SH, Li H, Rogers BE, Katzenellenbogen JA. Preliminary evaluation of a novel F-labeled PARP-1 ligand for PET imaging of PARP-1 expression in prostate cancer. Nuclear Medicine and Biology. 66: 26-31. PMID 30195072 DOI: 10.1016/J.Nucmedbio.2018.08.003 |
0.591 |
|
| 2018 |
Bandara N, Stott Reynolds TJ, Schehr R, Bandari RP, Diebolder PJ, Krieger S, Xu J, Miao Y, Rogers BE, Smith CJ. Matched-pair, Y/Y-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer. Nuclear Medicine and Biology. 62: 71-77. PMID 29929115 DOI: 10.1016/J.Nucmedbio.2018.06.001 |
0.789 |
|
| 2018 |
Bandara N, Jacobson O, Mpoy C, Chen X, Rogers BE. Novel Structural Modification Based on Evans Blue Dye to Improve Pharmacokinetics of a Somastostatin Receptor Based Theranostic Agent. Bioconjugate Chemistry. PMID 29927587 DOI: 10.1021/Acs.Bioconjchem.8B00341 |
0.804 |
|
| 2018 |
Dehdashti F, Wu N, Bose R, Naughton MJ, Ma CX, Marquez-Nostra BV, Diebolder P, Mpoy C, Rogers BE, Lapi SE, Laforest R, Siegel BA. Evaluation of [Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer. Breast Cancer Research and Treatment. PMID 29442264 DOI: 10.1007/S10549-018-4696-Z |
0.676 |
|
| 2017 |
Puente P, Fettig N, Luderer MJ, Jin A, Shah S, Muz B, Kapoor V, Goddu SM, Salama NN, Tsien C, Thotala D, Shoghi K, Rogers B, Azab AK. Injectable Hydrogels for Localized Chemo- and Radio-Therapy in Brain Tumors. Journal of Pharmaceutical Sciences. PMID 29162424 DOI: 10.1016/J.Xphs.2017.10.042 |
0.55 |
|
| 2017 |
Bandara N, Sharma AK, Krieger S, Schultz JW, Han BH, Rogers BE, Mirica LM. Evaluation of (64)Cu-based Radiopharmaceuticals that Target Aβ Peptide Aggregates as Diagnostic Tools for Alzheimer's Disease. Journal of the American Chemical Society. PMID 28823165 DOI: 10.1021/Jacs.7B05937 |
0.799 |
|
| 2017 |
Koh EI, Robinson AE, Bandara N, Rogers BE, Henderson JP. Copper import in Escherichia coli by the yersiniabactin metallophore system. Nature Chemical Biology. PMID 28759019 DOI: 10.1038/Nchembio.2441 |
0.781 |
|
| 2017 |
Floberg J, Rashmi R, Zhou D, Chu W, Bandara N, Rogers B, Shoghi K, Schwarz J. Characterizing Oxidative Stress in Cervical Cancer Cell Lines Using a Novel Positron Emission Tomography Probe [F-18]Dihydroethidium: Implications for Radiation and Redox Directed Therapies International Journal of Radiation Oncology*Biology*Physics. 99: E590. DOI: 10.1016/J.Ijrobp.2017.06.2021 |
0.769 |
|
| 2016 |
Rashmi R, DeSelm C, Helms C, Bowcock A, Rogers BE, Rader J. Correction: AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake (PLoS One.(2014)9:4 (e92948)Doi: 10.1371/journal.pone.0092948) Plos One. 11. PMID 28886011 DOI: 10.1371/Journal.Pone.0155168 |
0.527 |
|
| 2016 |
Kapoor V, Dadey DY, Nguyen K, Wildman SA, Hoye K, Khudanyan A, Bandara N, Rogers BE, Thotala D, Hallahan DE. Tumor specific binding of radiolabeled PEGylated GIRLRG peptide; a novel agent for targeting cancers. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27445290 DOI: 10.2967/Jnumed.115.165118 |
0.801 |
|
| 2016 |
Luderer MJ, Muz B, de la Puente P, Chavalmane S, Kapoor V, Marcelo R, Biswas P, Thotala D, Rogers B, Azab AK. A Hypoxia-Targeted Boron Neutron Capture Therapy Agent for the Treatment of Glioma. Pharmaceutical Research. PMID 27401411 DOI: 10.1007/S11095-016-1977-2 |
0.58 |
|
| 2016 |
Yan H, Kapoor V, Nguyen K, Akers WJ, Li H, Scott J, Laforest R, Rogers B, Thotala D, Hallahan D. Anti-tax interacting protein-1 (TIP-1) monoclonal antibody targets human cancers. Oncotarget. PMID 27270318 DOI: 10.18632/Oncotarget.9713 |
0.598 |
|
| 2016 |
Richter S, Wuest M, Bergman CN, Krieger S, Rogers BE, Wuest F. Metabolically-stabilized 68Ga-NOTA-bombesin for PET Imaging of prostate cancer and influence of protease inhibitor Phosphoramidon. Molecular Pharmaceutics. PMID 26973098 DOI: 10.1021/acs.molpharmaceut.5b00970 |
0.622 |
|
| 2016 |
Kapoor V, Dadey D, Nguyen K, Li H, Rogers B, Thotala D, Hallahan D. Abstract 4202: Peptide probes binding to radiation-inducible cell surface GRP78 as a novel targeting strategy for various tumors Cancer Research. 76: 4202-4202. DOI: 10.1158/1538-7445.Am2016-4202 |
0.641 |
|
| 2015 |
Kang CS, Wu N, Chen Y, Sun X, Bandara N, Liu D, Lewis MR, Rogers BE, Chong HS. Transferrin conjugates of triazacyclononane-based bifunctional NE3TA chelates for PET imaging: Synthesis, Cu-64 radiolabeling, and in vitro and in vivo evaluation. Journal of Inorganic Biochemistry. 154: 60-66. PMID 26583705 DOI: 10.1016/J.Jinorgbio.2015.10.012 |
0.823 |
|
| 2015 |
Lears KA, Parry JJ, Andrews R, Nguyen K, Wadas TJ, Rogers BE. Adenoviral-mediated imaging of gene transfer using a somatostatin receptor-cytosine deaminase fusion protein. Cancer Gene Therapy. 22: 215-21. PMID 25837665 DOI: 10.1038/Cgt.2015.14 |
0.582 |
|
| 2015 |
Richter S, Wuest M, Bergman CN, Way JD, Krieger S, Rogers BE, Wuest F. Rerouting the metabolic pathway of (18)F-labeled peptides: the influence of prosthetic groups. Bioconjugate Chemistry. 26: 201-12. PMID 25572982 DOI: 10.1021/bc500599m |
0.59 |
|
| 2015 |
Yan H, Nguyen K, Kapoor V, Mnich S, Scott J, Li H, Rogers B, Thotala D, Hallahan D. Abstract 4368: Targeting of a radiation inducible tax-interaction protein 1 (Tip 1) as a novel molecule for cancer treatment Cancer Research. 75: 4368-4368. DOI: 10.1158/1538-7445.Am2015-4368 |
0.548 |
|
| 2015 |
Kapoor V, Dadey D, Nguyen K, Li H, Rogers B, Thotala D, Hallahan D. Abstract 1791: Targeting radiation-inducible cell surface GRP78 using GIRLRG peptide as a novel imaging and therapeutic strategy for tumors Cancer Research. 75: 1791-1791. DOI: 10.1158/1538-7445.Am2015-1791 |
0.633 |
|
| 2014 |
Liu L, Rogers BE, Aladyshkina N, Cheng B, Lokitz SJ, Curiel DT, Mathis JM. Construction and Radiolabeling of Adenovirus Variants that Incorporate Human Metallothionein into Protein IX for Analysis of Biodistribution. Molecular Imaging. 13: 7290201400022. PMID 28650294 DOI: 10.2310/7290.2014.00022 |
0.566 |
|
| 2014 |
Dmitriev IP, Kashentseva EA, Kim KH, Matthews QL, Krieger SS, Parry JJ, Nguyen KN, Akers WJ, Achilefu S, Rogers BE, Alvarez RD, Curiel DT. Monitoring of biodistribution and persistence of conditionally replicative adenovirus in a murine model of ovarian cancer using capsid-incorporated mCherry and expression of human somatostatin receptor subtype 2 gene. Molecular Imaging. 13. PMID 25249483 DOI: 10.2310/7290.2014.00024 |
0.629 |
|
| 2014 |
Zhao ZQ, Wan L, Liu XY, Huo FQ, Li H, Barry DM, Krieger S, Kim S, Liu ZC, Xu J, Rogers BE, Li YQ, Chen ZF. Cross-inhibition of NMBR and GRPR signaling maintains normal histaminergic itch transmission. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 12402-14. PMID 25209280 DOI: 10.1523/Jneurosci.1709-14.2014 |
0.533 |
|
| 2014 |
Liu L, Rogers BE, Aladyshkina N, Cheng B, Lokitz SJ, Curiel DT, Mathis JM. Construction and radiolabeling of adenovirus variants that incorporate human metallothionein into protein IX for analysis of biodistribution. Molecular Imaging. 13. PMID 25060486 DOI: 10.2310/7290.2014.00022 |
0.566 |
|
| 2014 |
Cai Z, Ouyang Q, Zeng D, Nguyen KN, Modi J, Wang L, White AG, Rogers BE, Xie XQ, Anderson CJ. 64Cu-labeled somatostatin analogues conjugated with cross-bridged phosphonate-based chelators via strain-promoted click chemistry for PET imaging: in silico through in vivo studies. Journal of Medicinal Chemistry. 57: 6019-29. PMID 24983404 DOI: 10.1021/Jm500416F |
0.625 |
|
| 2014 |
Marquez BV, Ikotun OF, Parry JJ, Rogers BE, Meares CF, Lapi SE. Development of a Radiolabeled Irreversible Peptide Ligand for PET Imaging of Vascular Endothelial Growth Factor. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1029-34. PMID 24732153 DOI: 10.2967/Jnumed.113.130898 |
0.737 |
|
| 2014 |
Rashmi R, DeSelm C, Helms C, Bowcock A, Rogers BE, Rader JL, Rader J, Grigsby PW, Schwarz JK. AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake. Plos One. 9: e92948. PMID 24705275 DOI: 10.1371/Journal.Pone.0092948 |
0.537 |
|
| 2014 |
Li H, Zhou H, Krieger S, Parry JJ, Whittenberg JJ, Desai AV, Rogers BE, Kenis PJ, Reichert DE. Triazine-based tool box for developing peptidic PET imaging probes: syntheses, microfluidic radiolabeling, and structure-activity evaluation. Bioconjugate Chemistry. 25: 761-72. PMID 24661266 DOI: 10.1021/Bc500034N |
0.633 |
|
| 2014 |
Sin I, Kang CS, Bandara N, Sun X, Zhong Y, Rogers BE, Chong HS. Novel hexadentate and pentadentate chelators for â¶â´Cu-based targeted PET imaging. Bioorganic & Medicinal Chemistry. 22: 2553-62. PMID 24657050 DOI: 10.1016/J.Bmc.2014.02.041 |
0.799 |
|
| 2014 |
Bandara N, Cherukuri K, Krieger S, Parry J, Lapi S, Rogers B. Targeting Gastrin-Releasing Peptide Receptor-Positive Tumors using Yttrium-86 labeled DOTA-Bombesin(7-14) Analogs Nuclear Medicine and Biology. 41: 640. DOI: 10.1016/J.Nucmedbio.2014.05.144 |
0.783 |
|
| 2014 |
Kapoor V, Nguyen K, Yan H, Li H, Rogers B, Thotala D, Hallahan D. Monoclonal Antibody 2C6F3 Against Radiation-Inducible Cell Surface Tip-1 as a Novel Agent for Imaging and Targeting Tumors International Journal of Radiation Oncology*Biology*Physics. 90: S794. DOI: 10.1016/J.Ijrobp.2014.05.2294 |
0.581 |
|
| 2013 |
Richter S, Wuest M, Krieger SS, Rogers BE, Friebe M, Bergmann R, Wuest F. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer. Nuclear Medicine and Biology. 40: 1025-34. PMID 23969085 DOI: 10.1016/j.nucmedbio.2013.07.005 |
0.604 |
|
| 2013 |
Guo Y, Parry JJ, Laforest R, Rogers BE, Anderson CJ. The role of p53 in combination radioimmunotherapy with 64Cu-DOTA-cetuximab and cisplatin in a mouse model of colorectal cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1621-9. PMID 23873478 DOI: 10.2967/Jnumed.112.118539 |
0.63 |
|
| 2012 |
Chang AJ, Desilva R, Jain S, Lears K, Rogers B, Lapi S. 89Zr-Radiolabeled Trastuzumab Imaging in Orthotopic and Metastatic Breast Tumors. Pharmaceuticals (Basel, Switzerland). 5: 79-93. PMID 24288044 DOI: 10.3390/Ph5010079 |
0.7 |
|
| 2012 |
Nanda PK, Wienhoff BE, Rold TL, Sieckman GL, Szczodroski AF, Hoffman TJ, Rogers BE, Smith CJ. Positron-emission tomography (PET) imaging agents for diagnosis of human prostate cancer: agonist vs. antagonist ligands. In Vivo (Athens, Greece). 26: 583-92. PMID 22773572 |
0.65 |
|
| 2012 |
De Silva RA, Jain S, Lears KA, Chong HS, Kang CS, Sun X, Rogers BE. Copper-64 radiolabeling and biological evaluation of bifunctional chelators for radiopharmaceutical development. Nuclear Medicine and Biology. 39: 1099-104. PMID 22743158 DOI: 10.1016/J.Nucmedbio.2012.05.009 |
0.597 |
|
| 2012 |
Parry JJ, Chen R, Andrews R, Lears KA, Rogers BE. Identification of critical residues involved in ligand binding and G protein signaling in human somatostatin receptor subtype 2. Endocrinology. 153: 2747-55. PMID 22495673 DOI: 10.1210/en.2011-1662 |
0.544 |
|
| 2012 |
Craft JM, De Silva RA, Lears KA, Andrews R, Liang K, Achilefu S, Rogers BE. In vitro and in vivo evaluation of a 64Cu-labeled NOTA-Bn-SCN-Aoc-bombesin analogue in gastrin-releasing peptide receptor expressing prostate cancer. Nuclear Medicine and Biology. 39: 609-16. PMID 22261146 DOI: 10.1016/J.Nucmedbio.2011.12.004 |
0.657 |
|
| 2012 |
Schwarz JK, Payton JE, Rashmi R, Xiang T, Jia Y, Huettner P, Rogers BE, Yang Q, Watson M, Rader JS, Grigsby PW. Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 1464-71. PMID 22235101 DOI: 10.1158/1078-0432.Ccr-11-2485 |
0.571 |
|
| 2012 |
Nguyen K, Parry JJ, Rogers BE, Anderson CJ. Evaluation of copper-64-labeled somatostatin agonists and antagonist in SSTr2-transfected cell lines that are positive and negative for p53: implications for cancer therapy. Nuclear Medicine and Biology. 39: 187-97. PMID 22056254 DOI: 10.1016/J.Nucmedbio.2011.08.006 |
0.632 |
|
| 2012 |
Chang A, Nguyen K, Rogers B, Laforest R, Anderson C. PD-0532 64CU-RADIOLABELED OCTREOTATE AS A THERANOSTIC AGENT FOR CANCER: ROLE OF P53 IN THE THERAPEUTIC RESPONSE Radiotherapy and Oncology. 103: S213. DOI: 10.1016/S0167-8140(12)70871-X |
0.575 |
|
| 2011 |
Lears KA, Ferdani R, Liang K, Zheleznyak A, Andrews R, Sherman CD, Achilefu S, Anderson CJ, Rogers BE. In vitro and in vivo evaluation of 64Cu-labeled SarAr-bombesin analogs in gastrin-releasing peptide receptor-expressing prostate cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 470-7. PMID 21321264 DOI: 10.2967/Jnumed.110.082826 |
0.661 |
|
| 2010 |
Chen R, Parry JJ, Akers WJ, Berezin MY, El Naqa IM, Achilefu S, Edwards WB, Rogers BE. Multimodality imaging of gene transfer with a receptor-based reporter gene. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1456-63. PMID 20720053 DOI: 10.2967/Jnumed.109.063586 |
0.608 |
|
| 2009 |
Kitamura T, Fukuyo Y, Inoue M, Horikoshi NT, Shindoh M, Rogers BE, Usheva A, Horikoshi N. Mutant p53 disrupts the stress MAPK activation circuit induced by ASK1-dependent stabilization of Daxx. Cancer Research. 69: 7681-8. PMID 19789335 DOI: 10.1158/0008-5472.CAN-09-2133 |
0.533 |
|
| 2009 |
Geng L, Rachakonda G, Morré DJ, Morré DM, Crooks PA, Sonar VN, Roti JL, Rogers BE, Greco S, Ye F, Salleng KJ, Sasi S, Freeman ML, Sekhar KR. Indolyl-quinuclidinols inhibit ENOX activity and endothelial cell morphogenesis while enhancing radiation-mediated control of tumor vasculature. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 2986-95. PMID 19395476 DOI: 10.1096/Fj.09-130005 |
0.576 |
|
| 2008 |
Parry JJ, Sharma V, Andrews R, Moros EG, Piwnica-Worms D, Rogers BE. PET imaging of heat-inducible suicide gene expression in mice bearing head and neck squamous cell carcinoma xenografts. Cancer Gene Therapy. 16: 161-70. PMID 18758434 DOI: 10.1038/cgt.2008.70 |
0.59 |
|
| 2008 |
Edwards WB, Xu B, Akers W, Cheney PP, Liang K, Rogers BE, Anderson CJ, Achilefu S. Agonist-antagonist dilemma in molecular imaging: evaluation of a monomolecular multimodal imaging agent for the somatostatin receptor. Bioconjugate Chemistry. 19: 192-200. PMID 18020401 DOI: 10.1021/Bc700291M |
0.651 |
|
| 2007 |
Eiblmaier M, Andrews R, Laforest R, Rogers BE, Anderson CJ. Nuclear uptake and dosimetry of 64Cu-labeled chelator somatostatin conjugates in an SSTr2-transfected human tumor cell line. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 1390-6. PMID 17631550 DOI: 10.2967/Jnumed.107.039990 |
0.622 |
|
| 2007 |
Parry JJ, Kelly TS, Andrews R, Rogers BE. In vitro and in vivo evaluation of 64Cu-labeled DOTA-linker-bombesin(7-14) analogues containing different amino acid linker moieties. Bioconjugate Chemistry. 18: 1110-7. PMID 17503761 DOI: 10.1021/bc0603788 |
0.64 |
|
| 2007 |
Biddlecombe GB, Rogers BE, de Visser M, Parry JJ, de Jong M, Erion JL, Lewis JS. Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14). Bioconjugate Chemistry. 18: 724-30. PMID 17378600 DOI: 10.1021/Bc060281L |
0.662 |
|
| 2007 |
Parry JJ, Eiblmaier M, Andrews R, Meyer LA, Higashikubo R, Anderson CJ, Rogers BE. Characterization of somatostatin receptor subtype 2 expression in stably transfected A-427 human cancer cells. Molecular Imaging. 6: 56-67. PMID 17311765 DOI: 10.2310/7290.2007.00001 |
0.631 |
|
| 2007 |
Parry JJ, Andrews R, Rogers BE. MicroPET imaging of breast cancer using radiolabeled bombesin analogs targeting the gastrin-releasing peptide receptor. Breast Cancer Research and Treatment. 101: 175-83. PMID 16838112 DOI: 10.1007/s10549-006-9287-8 |
0.632 |
|
| 2005 |
Rogers BE, Parry JJ, Andrews R, Cordopatis P, Nock BA, Maina T. MicroPET imaging of gene transfer with a somatostatin receptor-based reporter gene and (94m)Tc-Demotate 1. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 1889-97. PMID 16269604 |
0.555 |
|
| 2005 |
Rogers BE, Roberson PL, Shen S, Khazaeli MB, Carpenter M, Yokoyama S, Brechbiel MW, LoBuglio AF, Buchsbaum DJ. Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region. Cancer Biotherapy & Radiopharmaceuticals. 20: 502-13. PMID 16248766 DOI: 10.1089/Cbr.2005.20.502 |
0.578 |
|
| 2005 |
Whitehead TD, Brownstein BH, Parry JJ, Thompson D, Cha BA, Moros EG, Rogers BE, Roti Roti JL. Expression of the proto-oncogene Fos after exposure to radiofrequency radiation relevant to wireless communications Radiation Research. 164: 420-430. PMID 16187744 DOI: 10.1667/RR3446.1 |
0.513 |
|
| 2005 |
Rogers BE, Roberson PL, Shen S, Khazaeli MB, Carpenter M, Yokoyama S, Brechbiel MW, LoBuglio AF, Buchsbaum DJ. Erratum: Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region (Cancer Biotherapy and Radiopharmaceuticals (2005) 20, 5 (502-513)) Cancer Biotherapy and Radiopharmaceuticals. 20. DOI: 10.1089/Cbr.2005.20.671 |
0.53 |
|
| 2004 |
Rogers BE, Manna DD, Safavy A. In Vitro and In Vivo Evaluation of a 64Cu-Labeled Polyethylene Glycol-Bombesin Conjugate Cancer Biotherapy and Radiopharmaceuticals. 19: 25-34. PMID 15068608 DOI: 10.1089/108497804773391649 |
0.637 |
|
| 2004 |
Bonner JA, Buchsbaum DJ, Rogers BE, Grizzle WE, Trummell HQ, Curiel DT, Fiveash JB, Ove R, Raisch KP. Adenoviral vector-mediated augmentation of epidermal growth factor receptor (EGFr) enhances the radiosensitization properties of anti-EGFr treatment in prostate cancer cells. International Journal of Radiation Oncology, Biology, Physics. 58: 950-8. PMID 14967455 DOI: 10.1016/J.Ijrobp.2003.09.095 |
0.554 |
|
| 2003 |
Rogers BE, Bigott HM, McCarthy DW, Della Manna D, Kim J, Sharp TL, Welch MJ. MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue. Bioconjugate Chemistry. 14: 756-63. PMID 12862428 DOI: 10.1021/Bc034018L |
0.67 |
|
| 2003 |
Roberson PL, Yokoyama S, Rogers BE, Buchsbaum DJ. Three-dimensional dose model for the comparison of 177Lu-HuCC49DeltaCH2 and 177Lu-HuCC49 radioimunotherapy in mice bearing intraperitoneal xenografts. Cancer Biotherapy & Radiopharmaceuticals. 18: 239-47. PMID 12804050 DOI: 10.1089/108497803765036418 |
0.558 |
|
| 2003 |
Rogers BE, Chaudhuri TR, Reynolds PN, Della Manna D, Zinn KR. Non-invasive gamma camera imaging of gene transfer using an adenoviral vector encoding an epitope-tagged receptor as a reporter. Gene Therapy. 10: 105-14. PMID 12571639 DOI: 10.1038/sj.gt.3301853 |
0.598 |
|
| 2002 |
Hemminki A, Zinn KR, Liu B, Chaudhuri TR, Desmond RA, Rogers BE, Barnes MN, Alvarez RD, Curiel DT. In vivo molecular chemotherapy and noninvasive imaging with an infectivity-enhanced adenovirus. Journal of the National Cancer Institute. 94: 741-9. PMID 12011224 DOI: 10.1093/Jnci/94.10.741 |
0.605 |
|
| 2002 |
Zinn KR, Chaudhuri TR, Krasnykh VN, Buchsbaum DJ, Belousova N, Grizzle WE, Curiel DT, Rogers BE. Gamma camera dual imaging with a somatostatin receptor and thymidine kinase after gene transfer with a bicistronic adenovirus in mice. Radiology. 223: 417-25. PMID 11997547 DOI: 10.1148/Radiol.2232010501 |
0.602 |
|
| 2002 |
Rogers BE, Zinn KR, Lin CY, Chaudhuri TR, Buchsbaum DJ. Targeted radiotherapy with [(90)Y]-SMT 487 in mice bearing human nonsmall cell lung tumor xenografts induced to express human somatostatin receptor subtype 2 with an adenoviral vector. Cancer. 94: 1298-305. PMID 11877760 DOI: 10.1002/Cncr.10300 |
0.615 |
|
| 2001 |
Chaudhuri TR, Rogers BE, Buchsbaum DJ, Mountz JM, Zinn KR. A noninvasive reporter system to image adenoviral-mediated gene transfer to ovarian cancer xenografts. Gynecologic Oncology. 83: 432-8. PMID 11606113 DOI: 10.1006/Gyno.2001.6333 |
0.6 |
|
| 2001 |
Hemminki A, Belousova N, Zinn KR, Liu B, Wang M, Chaudhuri TR, Rogers BE, Buchsbaum DJ, Siegal GP, Barnes MN, Gomez-Navarro J, Curiel DT, Alvarez RD. An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression. Molecular Therapy : the Journal of the American Society of Gene Therapy. 4: 223-31. PMID 11545613 DOI: 10.1006/Mthe.2001.0446 |
0.581 |
|
| 2001 |
Chaudhuri TR, Mountz JM, Rogers BE, Partridge EE, Zinn KR. Light-based imaging of green fluorescent protein-positive ovarian cancer xenografts during therapy. Gynecologic Oncology. 82: 581-9. PMID 11520161 DOI: 10.1006/Gyno.2001.6297 |
0.591 |
|
| 2001 |
Rogers BE, Mccarthy DW, Sharp TL, Kim J, Manna DD, Kirkman R, Welch MJ. Evaluation of a 64Cu-labeled bombesin analogue for diagnosis of gastrin-releasing peptide receptor positive tumors by micropet imaging Journal of Labelled Compounds and Radiopharmaceuticals. 44. DOI: 10.1002/Jlcr.2580440128 |
0.631 |
|
| 2000 |
Reynolds PN, Zinn KR, Gavrilyuk VD, Balyasnikova IV, Rogers BE, Buchsbaum DJ, Wang MH, Miletich DJ, Grizzle WE, Douglas JT, Danilov SM, Curiel DT. A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy. 2: 562-78. PMID 11124057 DOI: 10.1006/Mthe.2000.0205 |
0.564 |
|
| 2000 |
Vallera DA, Kuroki DW, Panoskaltsis-Mortari A, Buchsbaum DJ, Rogers BE, Blazar BR. Molecular modification of a recombinant anti-CD3ε-directed immunotoxin by inducing terminal cysteine bridging enhances anti-GVHD efficacy and reduces organ toxicity in a lethal murine model Blood. 96: 1157-1165. PMID 10910937 DOI: 10.1182/Blood.V96.3.1157 |
0.554 |
|
| 2000 |
Dmitriev I, Kashentseva E, Rogers BE, Krasnykh V, Curiel DT. Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells. Journal of Virology. 74: 6875-84. PMID 10888627 DOI: 10.1128/Jvi.74.15.6875-6884.2000 |
0.567 |
|
| 1999 |
Chappell LL, Rogers BE, Khazaeli MB, Mayo MS, Buchsbaum DJ, Brechbiel MW. Improved synthesis of the bifunctional chelating agent 1,4,7,10- tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N',N'',N'''-tris(acetic acid)cyclododecane (PA-DOTA) Bioorganic and Medicinal Chemistry. 7: 2313-2320. PMID 10632041 DOI: 10.1016/S0968-0896(99)00171-6 |
0.514 |
|
| 1997 |
Rogers BE, Curiel DT, Mayo MS, Laffoon KK, Bright SJ, Buchsbaum DJ. Tumor localization of a radiolabeled bombesin analogue in mice bearing human ovarian tumors induced to excess the gastrin-releasing peptide receptor by an adenoviral vector Cancer. 80: 2419-2424. PMID 9406692 DOI: 10.1002/(Sici)1097-0142(19971215)80:12+<2419::Aid-Cncr13>3.0.Co;2-F |
0.587 |
|
| 1997 |
Crooks WJ, Choppin GR, Rogers BE, Welch MJ. Evaluation of the in vitro stability of gadolinium (III) polyoxometalates. Nuclear Medicine and Biology. 24: 123-5. PMID 9089704 DOI: 10.1016/S0969-8051(96)00124-2 |
0.525 |
|
| 1997 |
Campain JA, Goldman CK, Rogers B, Matassa AA, Sosnowski B, Harrison GS, Curiel DT. USE OF TROPISM-MODIFIED ADENOVIRUSES FOR TARGETED DNA DELIVERY TO AIDS-KS CELLS VIA THE FIBROBLAST GROWTH FACTOR-RECEPTOR PATHWAY. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14: A27. DOI: 10.1097/00042560-199704010-00086 |
0.539 |
|
| 1996 |
Motekaitis RJ, Rogers BE, Reichert DE, Martell AE, Welch MJ. Stability and Structure of Activated Macrocycles. Ligands with Biological Applications. Inorganic Chemistry. 35: 3821-3827. PMID 11666570 DOI: 10.1021/Ic960067G |
0.574 |
|
| 1996 |
Douglas JT, Rogers BE, Rosenfeld ME, Michael SI, Feng M, Curiel DT. Targeted gene delivery by tropism-modified adenoviral vectors. Nature Biotechnology. 14: 1574-8. PMID 9634824 DOI: 10.1038/Nbt1196-1574 |
0.57 |
|
| 1996 |
Rogers BE, Anderson CJ, Connett JM, Guo LW, Edwards WB, Sherman EL, Zinn KR, Welch MJ. Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism. Bioconjugate Chemistry. 7: 511-22. PMID 8853465 DOI: 10.1021/Bc9600372 |
0.595 |
|
| 1996 |
Connett JM, Anderson CJ, Guo LW, Schwarz SW, Zinn KR, Rogers BE, Siegel BA, Philpott GW, Welch MJ. Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu. Proceedings of the National Academy of Sciences of the United States of America. 93: 6814-8. PMID 8692901 DOI: 10.1073/Pnas.93.13.6814 |
0.614 |
|
| 1994 |
Rogers BE, Franano FN, Edwards WB, Connett JM, Anderson CJ, Duncan JR, Welch MJ. IDENTIFICATION OF METABOLITES OF IN-111-DTPA-MONOCLONAL ANTIBODIES AND ANTBODY FRAGMENTS IN VIVO Journal of Immunotherapy. 16: 165. DOI: 10.1097/00002371-199408000-00078 |
0.517 |
|
| Show low-probability matches. |